Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282126 · ClinicalTrials.gov registry record · NA
Potassium Citrate to Prevent Age Related Bone Loss
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT00282126 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 52 participants.
The verdict
NCT00282126, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Osteoporosis, a disease in which the bones become weak and are more likely to break, is a major health problem in the United States. Too much acid in the body appears to be linked to loss of calcium via urine, bone loss, and muscle breakdown. The purpose of this study is to determine the effect of various doses of potassium citrate, a supplement that can neutralize acid, on bone density and muscle mass in older, healthy adults.
Interventions
- DIETARY_SUPPLEMENT Potassium citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282126
The ClinicalTrials.gov registry entry for NCT00282126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potassium citrate is the first listed.
NCT00282126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282126 about?
NCT00282126 is a clinical study titled "Potassium Citrate to Prevent Age Related Bone Loss". Osteoporosis, a disease in which the bones become weak and are more likely to break, is a major health problem in the United States. Too much acid in the body appears to be linked to loss of calcium via urine, bone loss, and muscle breakdown. The purpose of this study is to determine the effect of v...
What is the current status of trial NCT00282126?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2006-01.
What interventions are being tested in trial NCT00282126?
The interventions under investigation include: Potassium citrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00282126?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.